Fig. 9From: Identification and validation a costimulatory molecule gene signature to predict the prognosis and immunotherapy response for hepatocellular carcinomaComparison of the immune status in high- and low-risk groups. A The immune status of HCC patients in high- and low-risk groups. Tumor purity, ESTIMATE score, immune score and stromal score of every sample were showed in the heatmap. B The box plot displayed the differences of enrichment scores of 16 types of immune cells and 13 immune-related pathways in high- and low-risk groups using Mann–Whitney test. C The differences of stromal score, immune score, ESTIMATE score and tumor purity in high- and -risk groups with violin plots. *** P < 0.001Back to article page